<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30588629</article-id>
<article-id pub-id-type="pmc">6418751</article-id>
<article-id pub-id-type="doi">10.1113/JP276014</article-id>
<article-id pub-id-type="publisher-id">TJP13387</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Cardiovascular</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Long QT syndrome caveolin‐3 mutations differentially modulate K<sub>v</sub>4 and Ca<sub>v</sub>1.2 channels to contribute to action potential prolongation</article-title>
<alt-title alt-title-type="left-running-head">L. Tyan and others</alt-title>
<alt-title alt-title-type="right-running-head">Impact of caveolin‐3 mutations on potassium and calcium currents</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp13387-cr-0001">
<name>
<surname>Tyan</surname>
<given-names>Leonid</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="tjp13387-note-0001">
<sup>†</sup>
</xref>
<xref ref-type="bio" rid="d35e56">*</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0002">
<name>
<surname>Foell</surname>
<given-names>Jason D.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="tjp13387-note-0001">
<sup>†</sup>
</xref>
<xref ref-type="bio" rid="d35e79">*</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0003">
<name>
<surname>Vincent</surname>
<given-names>Kevin P.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0004">
<name>
<surname>Woon</surname>
<given-names>Marites T.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0005">
<name>
<surname>Mesquitta</surname>
<given-names>Walatta T.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0006">
<name>
<surname>Lang</surname>
<given-names>Di</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0007">
<name>
<surname>Best</surname>
<given-names>Jabe M.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0008">
<name>
<surname>Ackerman</surname>
<given-names>Michael J.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0009">
<name>
<surname>McCulloch</surname>
<given-names>Andrew D.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1708-5675</contrib-id>
<xref ref-type="aff" rid="tjp13387-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="tjp13387-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0010">
<name>
<surname>Glukhov</surname>
<given-names>Alexey V.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2076-9688</contrib-id>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp13387-cr-0011">
<name>
<surname>Balijepalli</surname>
<given-names>Ravi C.</given-names>
</name>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp13387-cr-0012">
<name>
<surname>Kamp</surname>
<given-names>Timothy J.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2103-7876</contrib-id>
<address>
<email>tjk@medicine.wisc.edu</email>
</address>
<xref ref-type="aff" rid="tjp13387-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp13387-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<named-content content-type="organisation-division">Division of Cardiovascular Medicine</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="post-code">1111</named-content>
<named-content content-type="street">Highland Ave</named-content>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">WI</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp13387-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Bioengineering</named-content>
<institution>University of California San Diego</institution>
<named-content content-type="street">9500 Gilman Drive</named-content>
<named-content content-type="city">La Jolla</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp13387-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>University of California San Diego</institution>
<named-content content-type="street">9500 Gilman Drive</named-content>
<named-content content-type="city">La Jolla</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp13387-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Departments of Cardiovascular Medicine</named-content>
<named-content content-type="organisation-division">Pediatric and Adolescent Medicine and Molecular Pharmacology &amp; Experimental Therapeutics</named-content>
<named-content content-type="organisation-division">Divisions of Heart Rhythm Services and Pediatric Cardiology</named-content>
<named-content content-type="organisation-division">Windland Smith Rice Sudden Death Genomics Laboratory</named-content>
<institution>Mayo Clinic</institution>
<named-content content-type="street">200 First Street SW</named-content>
<named-content content-type="city">Rochester</named-content>
<named-content content-type="country-part">MN</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> T. J. Kamp: 8459 WIMR2, 1111 Highland Ave., Madison, WI 53705‐2275. Email: <email>tjk@medicine.wisc.edu</email><break></break></corresp>
<fn id="tjp13387-note-0001">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>597</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2019.597.issue-6</issue-id>
<fpage>1531</fpage>
<lpage>1551</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2019 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-597-1531.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="tjp13387-sec-0010">
<title>Key points</title>
<p>
<list id="tjp13387-list-0001" list-type="bullet"><list-item><p>Mutations in the caveolae scaffolding protein, caveolin‐3 (Cav3), have been linked to the long QT type 9 inherited arrhythmia syndrome (LQT9) and the cause of underlying action potential duration prolongation is incompletely understood.</p></list-item><list-item><p>In the present study, we show that LQT9 Cav3 mutations, F97C and S141R, cause mutation‐specific gain of function effects on Ca<sub>v</sub>1.2‐encoded L‐type Ca<sup>2+</sup> channels responsible for <italic>I</italic>
<sub>Ca,L</sub> and also cause loss of function effects on heterologously expressed K<sub>v</sub>4.2 and K<sub>v</sub>4.3 channels responsible for <italic>I</italic>
<sub>to</sub>.</p></list-item><list-item><p>A computational model of the human ventricular myocyte action potential suggests that the major ionic current change causing action potential duration prolongation in the presence of Cav3‐F97C is the slowly inactivating <italic>I</italic>
<sub>Ca,L</sub> but, for Cav3‐S141R, both increased <italic>I</italic>
<sub>Ca,L</sub> and increased late Na<sup>+</sup> current contribute equally to action potential duration prolongation.</p></list-item><list-item><p>Overall, the LQT9 Cav3‐F97C and Cav3‐S141R mutations differentially impact multiple ionic currents, highlighting the complexity of Cav3 regulation of cardiac excitability and suggesting mutation‐specific therapeutic approaches.</p></list-item></list>
</p>
</sec>
<sec id="tjp13387-sec-0020">
<title>Abstract</title>
<p>Mutations in the <italic>CAV3</italic> gene encoding caveolin‐3 (Cav3), a scaffolding protein integral to caveolae in cardiomyocytes, have been associated with the congenital long‐QT syndrome (LQT9). Initial studies demonstrated that LQT9‐associated Cav3 mutations, F97C and S141R, increase late sodium current as a potential mechanism to prolong action potential duration (APD) and cause LQT9. Whether these Cav3 LQT9 mutations impact other caveolae related ion channels remains unknown. We used the whole‐cell, patch clamp technique to characterize the effect of Cav3‐F97C and Cav3‐S141R mutations on heterologously expressed Ca<sub>v</sub>1.2+Ca<sub>v</sub>β<sub>2cN4</sub> channels, as well as K<sub>v</sub>4.2 and K<sub>v</sub>4.3 channels, in HEK 293 cells. Expression of Cav3‐S141R increased <italic>I</italic>
<sub>Ca,L</sub> density without changes in gating properties, whereas expression of Cav3‐F97C reduced Ca<sup>2+</sup>‐dependent inactivation of <italic>I</italic>
<sub>Ca,L</sub> without changing current density. The Cav3‐F97C mutation reduced current density and altered the kinetics of <italic>I</italic>
<sub>Kv4.2</sub> and <italic>I</italic>
<sub>Kv4.3</sub> and also slowed recovery from inactivation. Cav3‐S141R decreased current density and also slowed activation kinetics and recovery from inactivation of <italic>I</italic>
<sub>Kv4.2</sub> but had no effect on <italic>I</italic>
<sub>Kv4.3</sub>. Using the O'Hara–Rudy computational model of the human ventricular myocyte action potential, the Cav3 mutation‐induced changes in <italic>I</italic>
<sub>to</sub> are predicted to have negligible effect on APD, whereas blunted Ca<sup>2+</sup>‐dependent inactivation of <italic>I</italic>
<sub>Ca,L</sub> by Cav3‐F97C is predicted to be primarily responsible for APD prolongation, although increased <italic>I</italic>
<sub>Ca,L</sub> and late <italic>I</italic>
<sub>Na</sub> by Cav3‐S141R contribute equally to APD prolongation. Thus, LQT9 Cav3‐associated mutations, F97C and S141R, produce mutation‐specific changes in multiple ionic currents leading to different primary causes of APD prolongation, which suggests the use of mutation‐specific therapeutic approaches in the future.</p>
</sec>
</abstract>
<abstract abstract-type="toc" id="d35e561">
<title>Key points</title>
<p>
<list id="tjp13387-list-0002" list-type="bullet"><list-item><p>Mutations in the caveolae scaffolding protein, caveolin‐3 (Cav3), have been linked to the long QT type 9 inherited arrhythmia syndrome (LQT9) and the cause of underlying action potential duration prolongation is incompletely understood.</p></list-item><list-item><p>In the present study, we show that LQT9 Cav3 mutations, F97C and S141R, cause mutation‐specific gain of function effects on Ca<sub>v</sub>1.2‐encoded L‐type Ca<sup>2+</sup> channels responsible for <italic>I</italic>
<sub>Ca,L</sub> and also cause loss of function effects on heterologously expressed K<sub>v</sub>4.2 and K<sub>v</sub>4.3 channels responsible for <italic>I</italic>
<sub>to</sub>.</p></list-item><list-item><p>A computational model of the human ventricular myocyte action potential suggests that the major ionic current change causing action potential duration prolongation in the presence of Cav3‐F97C is the slowly inactivating <italic>I</italic>
<sub>Ca,L</sub> but, for Cav3‐S141R, both increased <italic>I</italic>
<sub>Ca,L</sub> and increased late Na<sup>+</sup> current contribute equally to action potential duration prolongation.</p></list-item><list-item><p>Overall, the LQT9 Cav3‐F97C and Cav3‐S141R mutations differentially impact multiple ionic currents, highlighting the complexity of Cav3 regulation of cardiac excitability and suggesting mutation‐specific therapeutic approaches.</p></list-item></list>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="tjp13387-kwd-0001">arrhythmia</kwd>
<kwd id="tjp13387-kwd-0002">cardiac electrophysiology</kwd>
<kwd id="tjp13387-kwd-0003">cardiac potassium current</kwd>
<kwd id="tjp13387-kwd-0004">voltage‐dependent calcium channel</kwd>
<kwd id="tjp13387-kwd-0005">caveola</kwd>
<kwd id="tjp13387-kwd-0006">computer modeling</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Institutes of Health</funding-source>
<award-id>R01 HL078878</award-id>
<award-id>P50 GM094503</award-id>
<award-id>R01 HL141214‐01</award-id>
<award-id>R01 HL105242</award-id>
<award-id>R01 HL137100</award-id>
<award-id>R01 HL122384</award-id>
<award-id>HL126273</award-id>
<award-id>P41 GM103426</award-id>
</award-group>
<award-group>
<funding-source>American Heart Association</funding-source>
<award-id>SDG 16SDG29120011</award-id>
</award-group>
<award-group>
<funding-source>postdoctoral fellowship</funding-source>
<award-id>17POST33370089</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="12"></fig-count>
<table-count count="1"></table-count>
<page-count count="21"></page-count>
<word-count count="10907"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp13387</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 March 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.1 mode:remove_FC converted:15.03.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="tjp13387-note-0002">
<p>Edited by: Don Bers &amp; Bjorn Knollmann</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>